News
Ebekozien, chief quality officer of the American Diabetes Association, said the nonprofit is seeing a shift with more devices ...
Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback